Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the predominant cause of familial Parkinson's disease. We previously reported that parkin-/- mice exhibit nigrostriatal deficits in the absence of nigral degeneration. Parkin has been shown to function as an E3 ubiquitin ligase. Loss of parkin function, therefore, has been hypothesized to cause nigral degeneration via an aberrant accumulation of its substrates. Here we employed a proteomic approach to determine whether loss of parkin function results in alterations in abundance and/or modification of proteins in the ventral midbrain of parkin-/- mice. Two-dimensional gel electrophoresis followed by mass spectrometry revealed decreased abundance of a number of proteins involved in mitochondrial function or oxidative stress. Consistent with reductions in several subunits of complexes I and IV, functional assays showed reductions in respiratory capacity of striatal mitochondria isolated from parkin-/- mice. Electron microscopic analysis revealed no gross morphological abnormalities in striatal mitochondria of parkin-/- mice. In addition, parkin-/- mice showed a delayed rate of weight gain, suggesting broader metabolic abnormalities. Accompanying these deficits in mitochondrial function, parkin-/- mice also exhibited decreased levels of proteins involved in protection from oxidative stress. Consistent with these findings, parkin-/- mice showed decreased serum antioxidant capacity and increased protein and lipid peroxidation. The combination of proteomic, genetic, and physiological analyses reveal an essential role for parkin in the regulation of mitochondrial function and provide the first direct evidence of mitochondrial dysfunction and oxidative damage in the absence of nigral degeneration in a genetic mouse model of Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, mitophagy deficiency favored by ablation of Prkn (Palacino et al, 2004; Pickrell et al, 2015) or Pink1 (Gautier et al, 2008) sensitizes mice to oxidative stress, while worsening neural damage when combined with mitochondrial dysfunction (mitochondrial DNA [mtDNA] mutator‐prkn/parkin‐KO mice) (Pickrell et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Palacino et al, 2004
In the citing paper
“Both Pink1 and Parkin knockout mice exhibit increased ROS levels and mitochondrial dysfunction (43, 44), and persistent increased ROS is one of the important factors in accelerating cellular senescence (42, 45).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [43]
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Research works printed but not linked: 5
- Jenner, 1996, Neurology, 47, 5161
- Koller, 1986, Neurology, 36
- Darios, 2003, Hum. Mol. Genet., 12, 517, 10.1093/hmg/ddg044 · doi:10.1093/hmg/ddg044 · Paper page
- Klose, 1999, Methods Mol. Biol., 112, 67
- Dubin, 1989, Mol. Cell. Biol., 9, 1083
Cited by
Items 501–600 of 1,000
Feng, S., Wang, Z., Yuan, Y., Sun, H., Chen, N., & Zhang, Y. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14699 · Cited by 47
Mitochondrial dysfunction and possible treatments in Parkinson's disease—a review
Shults, C. W. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.07.028 · Cited by 47
Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism
Pacelli, C., Rotundo, G., Lecce, L., Menga, M., Bidollari, E., Scrima, R., Cela, O., Piccoli, C., Cocco, T., Vescovi, A. L., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112772 · Cited by 47
Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
Tassone, A., Meringolo, M., Ponterio, G., Bonsi, P., Schirinzi, T., & Martella, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087221 · Cited by 47
Karri, V., Schuhmacher, M., & Kumar, V. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111257 · Cited by 47
Bonet‐Ponce, L., Sáez-Atiénzar, S., da Casa, C., Sancho-Pellúz, J., Barcia, J. M., Martínez‐Gil, N., Nava, E., Jordán, J., Romero, F. J., & Galindo, M. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9509-3 · Cited by 48
Serviddio, G., Davide Romano, A., Cassano, T., Bellanti, F., Altomare, E., & Vendemiale, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796904740 · Cited by 46
Functional Genomics meets neurodegenerative disorders
Hoerndli, F. J., David, D. C., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.002 · Cited by 46
Zabel, C., Nguyen, H. P., Hin, S. C., Hartl, D., Mao, L., & Klose, J. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.08.008 · Cited by 46
Self-citationHyun, D., Lee, M., Halliwell, B., & Jenner, P. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20638 · Cited by 46
Sun, R., Eriksson, S., & Wang, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381996 · Cited by 46
Gubellini, P., Picconi, B., Filippo, M. D., & Calabresi, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.001 · Cited by 45
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 45
Kubo, S., Hattori, N., & Mizuno, Y. (2006) · Movement Disorders · doi:10.1002/mds.20841 · Cited by 45
Sunanda, T., Ray, B., Mahalakshmi, A. M., Bhat, A., Rashan, L. J., Rungratanawanich, W., Song, B., Essa, M. M., Sakharkar, M. K., & Chidambaram, S. B. (2021) · Biomolecules · doi:10.3390/biom11111669 · Cited by 45
The role of mitochondrial-related nuclear genes in age-related common disease
Li, H., Slone, J. D., & Huang, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.012 · Cited by 46
Animal models in neurodegenerative diseases
Hirsch, É. C. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_11 · Cited by 44
Acharya, S., & Kim, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094299 · Cited by 44
Baptista, M. A. S., Dave, K. D., Sheth, N. P., Silva, S. N. D., Carlson, K. M., Aziz, Y. N., Fiske, B. K., Sherer, T., & Frasier, M. A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011940 · Cited by 44
Singh, N., Haldar, S., Tripathi, A. K., McElwee, M. K., Horback, K., & Beserra, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5874 · Cited by 45
Olfactory dysfunction and its related molecular mechanisms in Parkinson’s disease
Gu, Y., Zhang, J., Zhao, X., Nie, W., Xu, X., Liu, M., & Zhang, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380875 · Cited by 44
Parkin regulation of CHOP modulates susceptibility to cardiac endoplasmic reticulum stress
Han, K. K., Hassanzadeh, S., Singh, K., Menazza, S., Nguyen, T. T. M., Stevens, M. V., Nguyen, A., San, H., Anderson, S. A., Lin, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02339-2 · Cited by 44
Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations.
Vinish, M., Anand, A., & Prabhakar, S. K. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2260 · Cited by 44
Loss-of-Function Rodent Models for Parkin and PINK1
Oliveras-Salv´, M., Van Rompuy, A.-S., Heeman, B., Van den Haute, C., & Baekelandt, V. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11041 · Cited by 43
Lactobacilli modulated AMPK activity and prevented telomere shortening in ageing rats
Lew, L.-C., Hor, Y.-Y., Jaafar, M. H., Lau, A. S.-Y., Ong, J.-S., Chuah, L. O., Yap, K. P., Azzam, G., Azlan, A., & Liong, M. T. (2019) · Beneficial Microbes · doi:10.3920/bm2019.0058 · Cited by 43
The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review
Spano, M., Signorelli, M., Vitaliani, R., Aguglia, E., & Giometto, B. (2015) · Functional Neurology · doi:10.11138/fneur/2015.30.3.151 · Cited by 43
Leathem, A., Ortíz, T., Dennis, J. M., & Witting, P. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136923 · Cited by 43
Chang, J., Wu, S., Hoel, F., Cheng, Y.-S., Liu, K.-H., Hsieh, M., Hoel, A., Tronstad, K. J., Yan, K.-C., Hsieh, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30436 · Cited by 43
Regulation of mitochondrial dynamics and neurodegenerative diseases.
Han, X.-J., Tomizawa, K., Fujimura, A., Ohmori, I., Nishiki, T., Matsushita, M., & Matsui, H. (2011) · PubMed · doi:10.18926/amo/43824 · Cited by 42
The Roles of Peroxiredoxin 6 in Brain Diseases
Liao, J., Zhang, Y., Chen, X., & Zhang, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02427-5 · Cited by 42
Animal models of mitochondrial DNA transactions in disease and ageing
Oliveira, M. T., Garesse, R., & Kaguni, L. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.019 · Cited by 42
Rapoport, M., Saada, A., Elpeleg, O. N., & Lorberboum‐Galski, H. (2008) · Molecular Therapy · doi:10.1038/mt.2008.4 · Cited by 42
Halliwell, B. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2007 · Cited by 41
Functional Genomics meets neurodegenerative disorders
David, D. C., Hoerndli, F. J., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.001 · Cited by 41
Induction of parkin expression in the presence of oxidative stress
Yang, Y., Muqit, M. M. K., & Latchman, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04998.x · Cited by 41
Gene-Targeting Technologies for the Study of Neurological Disorders
Beglopoulos, V., & Shen, J. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:013 · Cited by 41
Self-citationRBR Ubiquitin Ligases: Diversification and Streamlining in Animal Lineages
Marín, I. (2009) · Journal of Molecular Evolution · doi:10.1007/s00239-009-9252-3 · Cited by 41
Campello, L., Esteve-Rudd, J., Bru‐Martínez, R., Herrero, M. T., Fernández‐Villalba, E., Cuenca, N., & Martín‐Nieto, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074439 · Cited by 40
Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction: A trembling balance
Manini, A., Abati, E., Comi, G. P., Corti, S. P., & Ronchi, D. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101578 · Cited by 40
Casarejos, M. J., Solano, R. M., Menéndez, J., Rodríguez‐Navarro, J. A., Correa, C., de Yébenes, J. G., & Mena, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03249.x · Cited by 40
The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 39
Transgenic animal models of neurodegeneration based on human genetic studies
Harvey, B. K., Richie, C. T., Hoffer, B. J., & Airavaara, M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0476-6 · Cited by 39
Detrimental deletions: mitochondria, aging and Parkinson's disease
Biskup, S., & Moore, D. J. (2006) · BioEssays · doi:10.1002/bies.20471 · Cited by 39
Mashima, K., Takahashi, S., Minami, K., Izawa, Y., Abe, T., Tsukada, N., Hishiki, T., Suematsu, M., Kajimura, M., & Suzuki, N. (2018) · ASN NEURO · doi:10.1177/1759091418775562 · Cited by 39
Proteomics in neurodegeneration – disease driven approaches
Schulenborg, T., Schmidt, O., van Hall, A., Meyer, H. E., Hamacher, M., & Marcus, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0512-8 · Cited by 39
BAX and SMAC regulate bistable properties of the apoptotic caspase system
McKenna, S., García-Gutiérrez, L., Matallanas, D., & Fey, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-82215-2 · Cited by 39
Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice
Diedrich, M., Mao, L., Bernreuther, C., Zabel, C., Nebrich, G., KLEENE, R. B., & Klose, J. (2008) · PROTEOMICS · doi:10.1002/pmic.200700754 · Cited by 39
Self-citationImpaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases
Shen, J. (2010) · Neurodegenerative Diseases · doi:10.1159/000285511 · Cited by 38
Self-citationGonzález, S. R., Mena, M. A., Lastres‐Becker, I., Serrano, A., de Yébenes, J. G., Ramos, J. A., & Fernández‐Ruíz, J. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.010 · Cited by 38
Agnihotri, S. K., Sun, L., Yee, B. K., Shen, R., Akundi, R. S., Zhi, L., Duncan, M. J., Cass, W. A., & Büeler, H. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.02.006 · Cited by 38
Oxidative switch drives mitophagy defects in dopaminergic parkin mutant patient neurons
Schwartzentruber, A., Boschian, C., Lopes, F. M., Myszczynska, M. A., New, E. J., Beyrath, J., Smeitink, J. A. M., Ferraiuolo, L., & Mortiboys, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-72345-4 · Cited by 38
GBA -associated PD: Neurodegeneration, altered membrane metabolism, and lack of energy failure
Brockmann, K., Hilker, R., Pilatus, U., Baudrexel, S., Srulijes, K., Magerkurth, J., Hauser, A., Schulte, C., Csóti, I., Merten, C. D., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dd369 · Cited by 38
Giguère, N., Pacelli, C., Saumure, C., Bourque, M.-J., Matheoud, D., Levesque, D., Slack, R. S., Park, D. S., & Trudeau, L.-É. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000499 · Cited by 37
Ma, P., Yun, J., Deng, H., & Guo, M. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-04-0243 · Cited by 37
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 37
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 37
Neuronal Preconditioning Requires the Mitophagic Activity of C-terminus of HSC70-Interacting Protein
Lizama, B. N., Palubinsky, A. M., Raveendran, V. A., Moore, A. M., Federspiel, J. D., Codreanu, S. G., Liebler, D. C., & McLaughlin, B. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0699-18.2018 · Cited by 37
Jęśko, H. M., Lenkiewicz, A. M., Wilkaniec, A., & Adamczyk, A. (2019) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-026 · Cited by 37
The impact of genetic research on our understanding of Parkinson’s disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83002-x · Cited by 36
Cho, K.-I., Searle, K. M., Webb, M., Yi, H., & Ferreira, P. A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1071-9 · Cited by 36
Hidden phenotypes of PINK1/Parkin knockout mice
Paul, S., & Pickrell, A. M. (2021) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2021.129871 · Cited by 36
Kurz, A., May, C., Schmidt, O., Müller, T., Stephan, C., Meyer, H. E., Gispert, S., Auburger, G. W. J., & Marcus, K. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0717-3 · Cited by 36
Guo, S., Cui, X.-L., & Rausch, W. (2016) · Europe PMC (PubMed Central) · Cited by 36
Hörmann, P., Delcambre, S., Hanke, J. E., Geffers, R., Leist, M., & Hiller, K. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00547-4 · Cited by 36
Convergent mechanisms in etiologically-diverse dystonias
Thompson, V. B., Jinnah, H. A., & Hess, E. J. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.641533 · Cited by 36
Gene therapy targeting mitochondrial pathway in Parkinson’s disease
Choong, C., & Mochizuki, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1616-4 · Cited by 35
The parkin protein as a therapeutic target in Parkinson's disease
Winklhofer, K. F. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.12.1543 · Cited by 35
Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
Biosa, A., Sánchez-Martínez, Á., Filograna, R., Terriente-Félix, A., Alam, S. M., Beltramini, M., Bubacco, L., Bisaglia, M., & Whitworth, A. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy069 · Cited by 35
α-synuclein and Parkinson’s disease: a proteomic view
Fasano, M., & Lopiano, L. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.239 · Cited by 35
Mitochondrial PKA mediates sperm motility
Mizrahi, R., & Breitbart, H. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.005 · Cited by 35
Mitochondria in Parkinson Disease: Back in Fashion With a Little Help From Genetics
Muqit, M. M. K., Gandhi, S., & Wood, N. W. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.649 · Cited by 34
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease: Insights From PINK1
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 34
Plant Polyphenols as Neuroprotective Agents in Parkinson’s Disease Targeting Oxidative Stress
Hor, S. L., Teoh, S. L., & Lim, W. L. (2019) · Current Drug Targets · doi:10.2174/1389450120666191017120505 · Cited by 34
Mitochondrial electron transport chain functions in long-lived Ames dwarf mice
Choksi, K. B., Nuss, J. E., DeFord, J. H., & Papaconstantinou, J. (2011) · Aging · doi:10.18632/aging.100357 · Cited by 34
Structure-based design and characterization of Parkin-activating mutations
Stevens, M., Croteau, N., Eldeeb, M. A., Antico, O., Zeng, Z. W., Toth, R. L., Durcan, T. M., Springer, W., Fon, E. A., Muqit, M. M. K., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202201419 · Cited by 34
Key, J., Mueller, A. K., Gispert, S., Matschke, L. A., Wittig, I., Corti, O., Münch, C., Decher, N., & Auburger, G. W. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.008 · Cited by 34
SERRANO, A., MENENDEZ, J., Casarejos, M. J., Solano, R. M., GALLEGO, E., Sánchez, M., Mena, M. A., & GARCIADEYEBENES, J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.003 · Cited by 34
Mitochondrial Targeting in Neurodegeneration: A Heme Perspective
Fiorito, V., Chiabrando, D., & Tolosano, E. (2018) · Pharmaceuticals · doi:10.3390/ph11030087 · Cited by 33
Neuroproteomics as a promising tool in Parkinson’s disease research
Pienaar, I. S., Daniels, W. M. U., & Götz, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0070-3 · Cited by 33
Bazylianska, V., SHARMA, A. K., Chauhan, H., Schneider, B. L., & Moszczyńska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010363 · Cited by 33
MacDougall, G., Brown, L. Y., Kantor, B., & Chiba‐Falek, O. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.001 · Cited by 33
Improved mitochondrial stress response in long‐lived Snell dwarf mice
Ozkurede, U., & Miller, R. A. (2019) · Aging Cell · doi:10.1111/acel.13030 · Cited by 33
Franco, R., Rivas‐Santisteban, R., Navarro, G., Pinna, A., & Reyes‐Resina, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094643 · Cited by 33
Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress
Yu, F., & Zhou, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.052 · Cited by 33
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity
Tribl, F., Marcus, K., Bringmann, G., Meyer, H. E., Gerlach, M., & Riederer, P. F. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0513-7 · Cited by 32
Trudler, D., Nash, Y., & Frenkel, D. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1399-z · Cited by 32
Hennis, M. R., Marvin, M. A., Taylor, C. M., & Goldberg, M. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.009 · Cited by 32
Self-citationSchlossmacher, M. G., Tomlinson, J. J., dos Santos, G. M., Shutinoski, B., Brown, E. G., Manuel, D. G., & Mestre, T. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13476 · Cited by 32
van der Merwe, C., Loos, B., Swart, C., Kinnear, C. J., Henning, F., van der Merwe, L., Pillay, K., Muller, N., Zaharie, D., Engelbrecht, L., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.151 · Cited by 32
Ding, Y., Xin, C., Zhang, C., Lim, K., Zhang, H., Fu, Z., Li, L., & Huang, W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00246 · Cited by 32
Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100348 · Cited by 32
Yang, H., Zhou, H., Li, B., Niu, G., & Chen, S. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9082-2 · Cited by 32
The Proteomics of Neurodegeneration
Johnson, M. D., Yu, L., Conrads, T. P., Kinoshita, Y., Uo, T., McBee, J. K., Veenstra, T. D., & Morrison, R. S. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505040-00006 · Cited by 32
Gawęda-Walerych, K., & Żekanowski, C. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1931 · Cited by 32
Sun, F., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00775.x · Cited by 31
CHIP Is an Essential Determinant of Neuronal Mitochondrial Stress Signaling
Palubinsky, A. M., Stankowski, J. N., Kale, A. C., Codreanu, S. G., Singer, R. J., Liebler, D. C., Stanwood, G. D., & McLaughlin, B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6102 · Cited by 31
Gąssowska-Dobrowolska, M., Olech-Kochańczyk, G., Culmsee, C., & Adamczyk, A. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s468609 · Cited by 31
Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases
Rodolfo, C., Ciccosanti, F., Giacomo, G. D., Piacentini, M., & Fimia, G. M. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.43 · Cited by 31
Killinger, B. A., Shah, M. M., & Moszczyńska, A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12496 · Cited by 31
Animal Models of Parkinson’s Disease
Blesa, J., Trigo‐Damas, I., Quiroga‐Varela, A., & del Rey, N. L. (2016) · InTech eBooks · doi:10.5772/63328 · Cited by 31
Metadata
- Authors
- Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Shen, Jie
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 18
- Pages
- 18614-18622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2140647923
- Cited by
- 995
- References
- 66
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 34 · 2023: 29 · 2022: 27 · 2021: 44 · 2020: 51 · 2019: 39 · 2018: 41 · 2017: 32 · 2016: 41 · 2015: 41 · 2014: 42 · 2013: 60 · 2012: 49
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6031 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- Parkin, Parkinson's disease, mitochondrial dysfunction, oxidative stress, E3 ubiquitin ligase, nigrostriatal pathway, complex I, cytochrome c oxidase, respiratory capacity, lipid peroxidation, protein peroxidation, serum antioxidant capacity, metabolic abnormalities
- MeSH terms
- Animals, Antioxidants, Basal Ganglia, Mitochondria, Oxidative Phosphorylation, Parkinson Disease, Protein Processing, Post-Translational, Weight Gain, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Cell Respiration, Mitochondrial Proteins, Mitochondrial Diseases, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.